Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized open-label Teverelix loading-dose study in advanced prostate cancer
2006-004572-13Phase 2Completed
- Sponsor
- Ardana
- Start
- Sep 2006
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of teverelix in prostate cancer (PCa) (2 arms), sponsored by Ardana. Primary endpoint: Duration of castration. Started Sep 2006; status: completed.
02
Drugs
teverelix
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2006-004572-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004572-13.